Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis

Rheumatology

Volumn 50, Issue 2, 2011, Pages 381-388

  Radner, Helga ^a   Smolen, Josef S ^a   Aletaha, Daniel ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Comorbidity; Disability; Disease activity; Physical function; Rheumatoid arthritis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CEREBROVASCULAR DISEASE; CHRONIC LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; DAILY LIFE ACTIVITY; DEMENTIA; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; FUNCTIONAL DISEASE; GENDER; HEALTH STATUS; HEART INFARCTION; HEMIPLEGIA; HUMAN; KIDNEY DISEASE; LEUKEMIA; LIVER DISEASE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE LINEAR REGRESSION ANALYSIS; PARAPLEGIA; PEPTIC ULCER; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SHORT FORM 36; SOLID TUMOR;

ACTIVITIES OF DAILY LIVING; AGED; ANALYSIS OF VARIANCE; ARTHRITIS, RHEUMATOID; COMORBIDITY; DISABILITY EVALUATION; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 78751695495     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq334     Document Type: Article

References (31)

1. Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet 2007;370:1861-74.
2. Mierau M, Schoels M, Gonda G, Fuchs J, Aletaha D, Smolen JS. Assessing remission in clinical practice. Rheumatology 2007;46:975-9.
3. Klareskog L, van der Heijde D, de Jager JP et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004;363:675-81.
4. Keystone EC, Genovese MC, Klareskog L et al. Golimumab, a human antibody to tumour necrosis factor alpha given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study. Ann Rheum Dis 2009;68:789-96.
5. Aletaha D, Strand V, Smolen JS, Ward MM. Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: a pooled analysis of clinical trial results. Ann Rheum Dis 2008;67:238-43.
6. Welsing PMJ, Landewe RBM, Van Riel PLCM et al. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis -a longitudinal analysis. Arthritis Rheum 2004;50:2082-93.
7. Aletaha D, Smolen J, Ward MM. Measuring function in rheumatoid arthritis - identifying reversible and irreversible components. Arthritis Rheum 2006;54:2784-92.
8. Drossaers-Bakker KW, de Buck M, van Zeben D, Zwinderman AH, Breedveld FC, Hazes JMW. Long-term course and outcome of functional capacity in rheumatoid arthritis - the effect of disease activity and radiologic damage over time. Arthritis Rheum 1999;42:1854-60.
9. Escalante A, del Rincon I. How much disability in rheumatoid arthritis is explained by rheumatoid arthritis? Arthritis Rheum 1999;42:1712-21.
10. Radner H, Smolen JS, Aletaha D. Impact of comorbidity on physical function in patients with rheumatoid arthritis. Ann Rheumatic Dis 2010;69:536-41.
11. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23: 137-45.
12. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
13. Aletaha D, Smolen JS. Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: clinical evaluation and cost analysis. Arthritis Rheum 2002;47:181-8.
14. Kapral T, Dernoschnig F, Machold KP et al. Remission by composite scores in rheumatoid arthritis: are ankles and feet important? Arthritis Res Ther 2007;9:R72.
15. Stamm TA, Aletaha D, Pflugbeil S et al. The use of databases for quality assessment in rheumatoid arthritis. Clin Exp Rheumatol 2007;25:S82-5.
16. Ware JE, Sherbourne CD. The Mos 36-Item Short-Form Health Survey (SF-36) 1. Conceptual-framework and item selection. Med Care 1992;30:473-83.
17. Charlson ME, Pompei P, Ales K, Mackenzie CR. Development and validation of a new method of classifying co-morbidity in longitudinal-studies. Clin Res 1986;34:A360.
18. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47:1245-51.
19. Aletaha D, Nell VP, Stamm T et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005;7:R796-806.
20. Aletaha D, Smolen JS. The American College of Rheumatology N (ACR-N) debate: going back into the middle of the tunnel? Comment on the articles by Siegel and Zhen and by Boers. Arthritis Rheum 2006;54:377-8.
21. Bullinger M. German translation and psychometric testing of the SF-36 Health Survey - preliminary-results from the Iqola Project. Soc Sci Med 1995;41:1359-66.
22. Tuominen R, Mottonen T, Suominen C, Vahlberg T, Tuominen S. Relative importance of the functional abilities comprising Health Assessment Questionnaire Disability Index among rheumatoid arthritis patients. Rheumatol Int 2010;30:1477-82.
23. Callahan LF, Bloch DA, Pincus T. Identification of work disability in rheumatoid-arthritis - physical, radiographic and laboratory variables do not add explanatory power to demographic and functional variables. J Clin Epidemiol 1992;45:127-38.
24. Pincus T, Callahan LF. Rheumatology function-tests - grip strength, walking time, button test and questionnaires document and predict long-term morbidity and mortality in rheumatoid-arthritis. J Rheumatol 1992;19:1051-7.
25. Wolfe F. A reappraisal of HAQ disability in rheumatoid arthritis. Arthritis Rheum 2000;43:2751-61.
26. Wolfe F, Michaud K, Gefeller O, Choi HK. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum 2003;48:1530-42.
27. Pincus T, Swearingen C, Wolfe F. Toward a multidimensional health assessment questionnaire (MDHAQ) -assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis and Rheumatism 1999;42:2220-30.
28. Fries JF, Bruce B, Ambrosini D, Lingala B, Ware JE. Better assessment of disability outcomes: item improvement is neglected but essential. Arthritis Rheum 2006;54:S534.
29. Scott DL. Radiological progression in established rheumatoid arthritis. J Rheumatol 2004;31:55-65.
30. Kapetanovic MC, Lindqvist E, Saxne T, Eberhardt K. Orthopaedic surgery in patients with rheumatoid arthritis over 20 years: prevalence and predictive factors of large joint replacement. Ann Rheum Dis 2008;67:1412-6.
31. Young A, Koduri G, Batley M et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology 2007;46:350-7.